Next, we tested the ability of canIL-13.E13K to neutralize the cytotoxic action of canIL-13.E13K-PE38QQR on human GBM BTCOE 4795 explant cells that over-express IL-13RA2. Here, IL13RA2 is linked to glioblastoma.